The mechanistic basis lies in CRP’s role in promoting myeloid-derived suppressor cell (MDSC) expansion and PD-L1 upregulation, while lymphocytopenia limits CD8+ T-cell-mediated tumor control (25). This evidence concerns the gene CRP and neoplasm.